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2 
Abstract  23 
Jaagsiekte sheep retrovirus (JSRV) is the etiologic agent of ovine pulmonary adenocarcinoma 24 
(OPA), a neoplastic lung disease of sheep.  OPA is an important economic and welfare issue for 25 
sheep farmers and a valuable naturally-occurring animal model for human lung adenocarcinoma.  26 
Here, we used RNA sequencing to study the transcriptional response of ovine lung tissue to 27 
infection by JSRV.  We identified 1,971 ovine genes differentially-expressed in JSRV-infected 28 
lung compared to non-infected lung, including many genes with roles in carcinogenesis and 29 
immunomodulation.  The differential expression of selected genes was confirmed using 30 
immunohistochemistry and RT-qPCR.  A key finding was the activation of anterior-gradient-2, 31 
yes-associated protein-1 and amphiregulin in OPA tumor cells, indicating a role for this 32 
oncogenic pathway in OPA.  In addition, there was differential expression of genes related to 33 
innate immunity including genes encoding cytokines, chemokines and complement system 34 
proteins.  In contrast, there was little evidence for upregulation of genes involved in T-cell 35 
immunity.  Many genes related to macrophage function were also differentially expressed, 36 
reflecting the increased abundance of these cells in OPA-affected lung tissue.  Comparison of the 37 
genes differentially regulated in OPA with transcriptional changes occurring in human lung 38 
cancer revealed important similarities and differences between OPA and human lung 39 
adenocarcinoma.  This study provides valuable new information on the pathogenesis of OPA and 40 
strengthens the use of this naturally occurring animal model for human lung adenocarcinoma. 41 
  42 
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Importance  43 
Ovine pulmonary adenocarcinoma is a chronic respiratory disease of sheep caused by jaagsiekte 44 
sheep retrovirus (JSRV).  OPA is a significant economic problem for sheep farmers in many 45 
countries and is a valuable animal model for some forms of human lung cancer.  Here, we 46 
examined changes in host gene expression that occur in the lung in response to JSRV infection.  47 
We identified a large number of genes with altered expression in infected lung, including factors 48 
with roles in cancer and immune system function.  We also compared the data from OPA to 49 
previously published data from human lung adenocarcinoma and found a large degree of overlap 50 
in the genes that were dysregulated.  The results of this study provide exciting new avenues for 51 
future studies of OPA and may have comparative relevance for understanding human lung 52 
cancer.  53 
  54 
Introduction 55 
Ovine pulmonary adenocarcinoma (OPA) is an infectious lung disease of sheep that is a 56 
significant economic problem and welfare concern for sheep producers in many countries (1, 2).  57 
The main clinical features of OPA are loss of condition and respiratory distress and in many 58 
advanced cases there is an accumulation of fluid in the lungs that drains from the sheep’s nostrils 59 
when its head is lowered (3).  Lung function is often further compromised by the presence of 60 
bacterial or parasitic co-infection (1).  By the time clinical signs become apparent, tumor growth 61 
is typically extensive and the disease is invariably fatal.  62 
 63 
OPA is caused by jaagsiekte sheep retrovirus (JSRV), an exogenous betaretrovirus (4).  Despite 64 
its etiological role in OPA, infected sheep produce only a limited adaptive immune response to 65 
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JSRV antigens and this has precluded the development of an effective preclinical serological 66 
diagnostic test or vaccine to control the spread of disease (2).  The mechanism underlying the 67 
poor immune responsiveness of sheep to JSRV is not completely understood.  It appears likely 68 
that it is largely due to immunological tolerance elicited by the developmental expression of 69 
closely related endogenous JSRV (enJSRV) proteins in the ovine fetal thymus (5, 6).  However, 70 
local immunomodulatory mechanisms are also proposed to contribute (7). 71 
 72 
JSRV has a specific tropism for differentiated epithelial cells of the distal lung and OPA tumor 73 
cells predominantly express markers of type II alveolar epithelial cells (AEC2) (8-10).  An 74 
unusual feature of JSRV is that the Env glycoprotein functions as a viral oncoprotein to drive 75 
neoplastic transformation in vitro (11, 12) and in vivo (13-16).  JSRV Env expression activates a 76 
number of signaling pathways that control cellular proliferation, including PI3K-Akt and MEK-77 
ERK1/2 (17, 18).  Several cellular factors that bind Env have been identified and are proposed to 78 
be involved in transformation (19-21) but further work is necessary to provide a complete model 79 
for Env-mediated tumorigenesis and to explain how this leads to the unique clinical presentation 80 
of OPA.   81 
 82 
In addition to its veterinary importance, OPA represents a valuable animal model for some forms 83 
of human lung cancer due to similarities in histological appearance and the activation of common 84 
oncogenic signaling pathways (22-25).  In its early stages; such as in subclinical natural disease 85 
and in experimentally-infected lambs, OPA resembles a minimally invasive adenocarcinoma 86 
with a predominantly lepidic growth pattern (22, 24).  In advanced natural disease, OPA is more 87 
closely similar to adenocarcinoma with papillary or acinar predominant growth with or without 88 
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mucinous features (22, 25).  The similarity of OPA to human lung adenocarcinoma suggests that 89 
this naturally occurring sheep tumor could be valuable for understanding lung carcinogenesis, 90 
particularly at the early stages of disease, which are difficult to diagnose and study in humans. 91 
 92 
In order to examine the pathogenesis of OPA, we determined changes in host gene expression in 93 
the lungs of lambs following experimental infection with JSRV.  Many genes were identified to 94 
have altered expression and we confirmed the upregulation of some of these using 95 
immunohistochemistry and RT-qPCR.  We also compared the differential gene expression of 96 
OPA-affected animals with previously published data on the two most common types of non-97 
small-cell lung carcinoma (NSCLC) in humans; lung adenocarcinoma (LUAD) and lung 98 
squamous cell carcinoma (LUSC).  Collectively, this study provides new information that greatly 99 
enhances our understanding of the host response to JSRV and provides a number of exciting new 100 
avenues for future work on OPA. 101 
 102 
RESULTS 103 
 104 
JSRV-induced gene expression in sheep lung tissue. 105 
Whole transcriptome profiling (RNA-Seq) was performed on lung samples derived from JSRV 106 
infected (n=4) and mock-infected (n=4) specific pathogen-free (SPF) lambs.  The samples used 107 
were obtained from a previous study (9) in which 6-day old lambs were infected with JSRV by 108 
intratracheal injection and euthanized when signs of respiratory distress appeared (66 – 85 days 109 
post-inoculation).  Mock-infected lung tissue came from age and sex-matched control lambs that 110 
had been inoculated with cell culture medium (9).  OPA tumor lesions were observed in 111 
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hematoxylin and eosin-stained lung tissue sections from infected lambs and confirmed with 112 
immunohistochemistry (IHC) for JSRV Env (SU) protein.  Such lesions were not present in lung 113 
tissue from mock-infected lambs (9).  Infected tissues contained many tumor foci distributed 114 
throughout the lung that otherwise appeared histologically normal, a pattern typical of 115 
experimentally-induced OPA (22).  Samples for RNA-Seq were generated by pooling tissue 116 
from 7 distinct sites of each lung. In order to capture specimens that were representative of the 117 
whole tissue the samples analyzed were not specifically enriched for tumor cells. 118 
 119 
RNA-Seq generated over 60 million reads per sample, of which approximately 80% mapped 120 
uniquely onto the ovine and JSRV genomes (Table 1).  A total of 15,149 sheep genes were 121 
identified and reads were quantified to identify those that were differentially expressed between 122 
mock-infected and JSRV-infected samples.  Principal component analysis of the normalized 123 
counts of sheep genes clearly separated the mock-infected and the JSRV-infected groups (Fig. 124 
1A).  JSRV infection produced a radical change in sheep gene expression with 1,971 125 
differentially expressed transcripts identified between the two groups (Fig. 1B) (1237 126 
upregulated and 734 downregulated).  We defined differentially expressed genes as those 127 
showing up or down regulation following JSRV infection with a false discovery rate (FDR) 128 
below 0.05, regardless of the observed fold-change.  The complete lists of mapped genes and 129 
differentially expressed genes are presented in Supplementary Dataset S1.  Hierarchical 130 
clustering of all differentially expressed genes is shown in Fig. 1C.  Fig. 1D summarizes the 25 131 
most significantly upregulated and downregulated genes.   132 
 133 
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Although the RNA-Seq analysis revealed clear differences in gene expression between the 134 
infected and control groups, one infected lamb (Infected_F_85days) showed an intermediate 135 
overall expression pattern (Fig 1A, 1C).  Of the four infected lambs, this animal had the lowest 136 
percentage of reads mapping to JSRV in the RNA-Seq data (Table 1) and therefore likely had the 137 
smallest proportion of tumor-affected tissue and the largest contribution from ‘healthy’ 138 
uninfected tissue.  Nevertheless, hierarchical clustering grouped this animal with the other 139 
infected lambs (Fig. 1C, D) and so it was included in subsequent analyses.  140 
 141 
Functional analysis of RNA-Seq data. 142 
KEGG pathway enrichment analysis of the upregulated and downregulated genes was performed 143 
using the DAVID annotation software (https://david.ncifcrf.gov/ (26)) (Supplementary Dataset 144 
S2).  Upregulated pathways in the OPA-affected lung included genes involved in metabolic 145 
pathways, epithelial cell differentiation, cell cycle and wound healing.  Pathways involved in 146 
immune response and inflammation were down-regulated.  Ingenuity Pathway Analysis (IPA) 147 
(27) was also used to functionally analyze the list of differentially expressed genes.  The main 148 
‘Diseases and Biofunctions’ related to the differentially expressed genes are shown in Fig. 2.  As 149 
with DAVID analysis, cancer related functions, such as cell proliferation and tissue 150 
development, were identified as highly enriched whereas those related to immune response and 151 
inflammation were less strongly represented.  These results revealed key signaling networks in 152 
cancer, including neovascularization, cell viability and tumor growth, to be activated in JSRV-153 
infected tissue compared to mock-infected tissue (Fig. 3).  Based on these analyses, we used IHC 154 
to validate selected upregulated markers, focusing in particular on pathways of relevance to OPA 155 
pathogenesis, as discussed below. 156 
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 157 
Cancer-related gene expression in OPA-affected lung tissue. 158 
Many of the most significantly upregulated genes in OPA have previously been associated with 159 
important aspects of tumorigenesis in mice and humans.  These include functions such as cell 160 
proliferation and differentiation (CLDN2, CTSL, PROM2, AGR2, EPHA7, SOX9, KRT18), 161 
angiogenesis (MMP9, CCLA2, EPHB2, CXCL8), metastasis (CCLA2, EPHB2, AGR2, HS6ST2, 162 
MUC1) and signal transduction, including EGF family members (AREG, EREG, NRG2) and Wnt 163 
signaling components (e.g., WNT10B, PPARG, KRT18, LEF1, AXIN2, FZD3, FZD5, ROR1, 164 
CTNNB1 and CDH1).   In addition, factors previously identified as specific markers of lung 165 
adenocarcinoma were upregulated, including PROM2, CLDN3 and TJP3, as were genes 166 
proposed to have potential diagnostic or prognostic value in human cancers, including MMP9, 167 
AGR2, SULF1, NHSL1, LGR5, MUC1 and PIK3C2G.   168 
 169 
Although several factors related to angiogenesis were found to be upregulated using RNA-Seq, a 170 
previous study reported that vascular endothelial growth factor (VEGF) signaling was 171 
downregulated in OPA (28).  The RNA-Seq data is consistent with that study, finding reduced 172 
expression of VEGFD, VEGFA and VEGFR2 (KDR) in JSRV-infected lambs, although only 173 
VEGFD passed our cut-off for statistical significance.  The upregulation of MMP9 in OPA-174 
affected lung tissue found by RNA-Seq is also in agreement with the previous study (28).  175 
 176 
The upregulation of AGR2 (anterior gradient-2) was of particular interest as this protein has been 177 
shown to promote oncogenesis in adenocarcinomas of several tissues, including the lung (29).  178 
To analyze the expression of AGR2 in OPA, IHC was performed on lung tissue sections from 179 
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natural and experimental OPA and mock-infected lambs.  The cytoplasm of bronchiolar 180 
epithelial cells of mock-infected lung labeled strongly for AGR2 but there was no labeling of 181 
cells in the alveolar compartment (Fig. 4A, D).  In contrast, in JSRV-infected lung, there were 182 
many regions of strong AGR2 labeling and these correlated closely with areas of JSRV-Env 183 
labeling in serial adjacent sections (Fig. 4B, C, E, F).  This was evident even on relatively small 184 
tumor foci suggesting that AGR2 is activated early following JSRV infection.  185 
Immunofluorescent labeling confirmed the co-expression of JSRV Env and AGR2 in infected 186 
lung tissue, although not every infected cell cluster labeled positively for AGR2 (Fig. 4G-J).  187 
AGR2 has been shown to stimulate the expression of the EGFR ligand amphiregulin (AREG) in 188 
adenocarcinoma cells (30).  AREG was also upregulated in OPA and, as for AGR2, IHC 189 
demonstrated positive labeling for AREG in OPA tumor cells from both natural and 190 
experimentally-induced disease (Fig. 4K-M).   191 
 192 
The activation of AREG by AGR2 is mediated by Yes-associated protein (YAP1), a nuclear 193 
effector of the Hippo signaling pathway (30), which led us to ask whether Hippo signaling is 194 
involved in OPA.  YAP1 was not found to be differentially expressed by RNA-Seq but to 195 
examine this question further, IHC was performed on tissue sections of mock-infected and OPA-196 
affected lung using antibodies to the phosphorylated form of YAP1 and to total YAP1 (Fig. 5).  197 
IHC detected both the phosphorylated and unphosphorylated forms of YAP1 in the bronchiolar 198 
epithelium and in the alveolar compartment of mock-infected lung (Fig. 5A, D).  As expected, 199 
the phosphorylated (inactive) form was predominantly detected in the cytoplasm, whereas an 200 
antibody to total YAP1 (which detects active and inactive forms) exhibited prominent nuclear 201 
labeling that was more intense than labeling of the cytoplasm.  Tumor cells in experimental OPA 202 
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had strong nuclear labeling for total YAP1 (Fig. 5B) but this appeared less intense in natural 203 
OPA (Fig. 5C).  IHC for regulators of the Hippo pathway, MST1/2 and LATS1/2, found these 204 
proteins were readily detectable in AEC2s in healthy sheep lung (Fig. 5G, J), as previously 205 
reported in mouse lung (31).  OPA tumor cells also labeled strongly for both markers (Fig. 5H, I, 206 
K, L).  Interestingly, the distribution of labeling for LATS1/2 differed between experimentally-207 
induced tumors and natural cases of OPA, being predominantly cytoplasmic in experimental 208 
disease and predominantly nuclear in natural disease.  While a complete analysis of the 209 
activation state of the Hippo pathway is outside the scope of this study, these data indicate that 210 
the AGR2-YAP1-AREG axis is active in OPA and may contribute to oncogenesis in this disease.   211 
 212 
Immune response to JSRV infection and oncogenesis. 213 
The RNA-Seq analysis identified altered expression of many genes related to immune responses 214 
including various cytokines and chemokines (e.g., CSF2, CCL2, CXCL6, CXCL8, CXCL14, 215 
IL1A, IL6, TGFB3 and TNFSF18 were upregulated and CSF1, CCL4, CCL18, CCL26, CXCL12, 216 
IL15 and TNF were downregulated), along with several members of the complement pathway 217 
(C3, C5, C6, C7, MBL1 (ENSOARG00000010165), CFI, CD46, PTX3, C4BPA, C4BPB 218 
upregulated and C1QA and C1QB downregulated), confirming a substantial host response to 219 
infection and tumor growth.  Selected cytokines were also evaluated by RT-qPCR in 220 
experimentally-induced and natural OPA and this confirmed their differential expression (Fig. 221 
6).  Interestingly, the expression data does not support strong induction of type I interferon 222 
responses in JSRV-infected lung.  Although IFNA was not identified using RNA-Seq, RT-qPCR 223 
analysis found it to be downregulated in natural OPA (Fig. 6).  Expression of IFNB1 was not 224 
significantly changed in JSRV-infected tissue.  Furthermore, when considering a recently 225 
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described panel of 90 highly conserved mammalian type-1 interferon-stimulated genes (32), only 226 
one (IRF7) was significantly upregulated in our data.   227 
 228 
IFNG expression was not significantly upregulated in cases of experimental OPA suggesting 229 
little or no activation of cellular Th1 responses in early disease.  However, RT-qPCR found that 230 
IFNG was increased in tissue from cases of advanced natural OPA (Fig. 6B), consistent with a 231 
previous report of IFNG-positive macrophages in natural OPA (7).  Markers of T-lymphocytes 232 
were either not significantly changed (CD3 (gamma, delta and epsilon chains) and CD4) or 233 
downregulated (CD8, alpha and beta chains).  Interestingly, expression of FOXP3 and CD44, 234 
both markers of regulatory T-cells (Tregs), was significantly increased in OPA.  Tregs negatively 235 
regulate T-cell immune responses through a number of mechanisms and have been shown to 236 
reduce the ability of CD8 T-cells to produce TNF (33).  Consistent with this, TNF expression 237 
was downregulated in experimentally and naturally-infected animals (Fig. 6).  238 
 239 
In agreement with previous studies (7, 34), macrophages were observed in many sections of the 240 
experimental OPA cases studied here. In addition, approximately 10% (198 of 1971) of the 241 
differentially expressed genes in our analysis have macrophage-related functions (Fig. 7; 242 
Supplementary Dataset S3), confirming that macrophage-related gene expression is altered in 243 
JSRV-infected tissue.  Upregulated genes include some previously associated with an 244 
inflammatory phenotype (e.g., HIF1A, IL1A, CXCL8, CSF2, IRAK1, IRF7) or an 245 
immunoregulatory phenotype (e.g., CD163, CCL2, LGMN, MMP9, MMP14), suggesting that a 246 
complex pattern of macrophage activation exists in OPA.  Selected macrophage markers were 247 
also studied by IHC.  Labeling for CD68, a commonly-used marker of monocytes and tissue 248 
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macrophages, identified cells located in normal alveolar lung tissue and along the margin of 249 
tumor foci (Fig. 8A-C).  In comparison, an antibody to CD163, a marker for macrophages with 250 
an immunomodulatory phenotype (35), labeled many more cells, including cells that surrounded 251 
or infiltrated the tumor foci (Fig. 8D-F).  Macrophages in or around OPA foci also labeled 252 
positively for legumain (LGMN), another marker associated with an immunoregulatory 253 
phenotype (Fig. 8G-I) and hypoxia-inducible factor 1-alpha (HIF1A, which is associated with an 254 
inflammatory macrophage phenotype (Fig. 8J-L).  LGMN was also detected in alveolar 255 
macrophages in mock-infected tissue, while HIF1A labeling in mock-infected lung was limited 256 
to the bronchiolar epithelium.  Interestingly, the antibodies to HIF1A and LGMN also labeled 257 
some tumor cells whereas anti-CD163 and anti-CD68 did not.  Consistent with the greater 258 
abundance of macrophages in OPA-affected lung, RNA-Seq identified increased expression of 259 
several myeloid cell chemoattractants (e.g., CCL2, CSF2, S100A8, S100A9, and CXCL8) in 260 
JSRV-infected tissues.  261 
 262 
Comparison of gene expression of ovine pulmonary adenocarcinoma with human lung 263 
adenocarcinoma. 264 
We next compared the RNA-Seq data from OPA with previously published expression data from 265 
the two most common types of NSCLC (LUAD and LUSC).  Gene counts data from RNA-Seq 266 
studies on tumors from patients with LUAD and LUSC were downloaded from The Cancer 267 
Genome Atlas (TCGA) database (portal.gdc.cancer.gov) (36).  Data were selected from patients 268 
for whom matched normal and tumor data were available (57 LUAD and 49 LUSC; 269 
Supplementary Dataset S4 shows their clinical annotation).  The genes differentially expressed 270 
between tumor and normal samples were identified in each clinical disease stage (LUAD I – IV 271 
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and LUSC I - III); (Supplementary Dataset S5).  To compare differentially expressed genes in 272 
sheep and human cancers, we considered only those sheep genes with one-to-one orthologues in 273 
humans (1726 out of 1971 (87%)).  We then compared the lists of differentially expressed 274 
orthologous genes between OPA and the different stages of human LUAD and LUSC by 275 
calculating the Pearson correlation coefficient between the log ratios of genes in common 276 
between the two lists.  The correlation plot of orthologous genes between OPA and the different 277 
stages of human LUAD and LUSC (Fig. 9A) revealed that the gene expression profile of OPA is 278 
more similar to LUAD than it is to LUSC and that OPA is more closely correlated with stage I 279 
LUAD than with later stages.  The main Diseases and Biofunctions associated with the 280 
differentially expressed orthologous genes in OPA and stage I LUAD were identified with IPA 281 
(Fig. 9B).  Supplementary Dataset S6 lists the fold-change of the genes differentially expressed 282 
in OPA with their human orthologues in LUAD and LUSC and identifies those genes with 283 
similar or divergent changes in expression between the two species.  Fig. 9C summarizes the 284 
fold-change of the 50 genes most significantly deregulated in OPA with their human orthologue 285 
from stage I LUAD.  Of these, 37 were consistent in their direction of change and 13 were 286 
discordant.   287 
 288 
DISCUSSION 289 
The pathogenesis of OPA is intriguing.  How does JSRV infection and expression of its 290 
oncogenic Env protein elicit the striking clinical and pathological phenotype typical of this 291 
disease?  As the mechanisms underlying this process remain largely undetermined, here we used 292 
a global RNA-Seq approach to gain insight into the gene pathways and networks that are altered 293 
during the early stages of OPA.  We identified 1971 differentially expressed sheep genes and 294 
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validated several of these by IHC or RT-qPCR.  Some changes revealed the altered cellular 295 
composition of infected and uninfected lung.  For example, the increased number of 296 
macrophages and the presence of tumor cells derived from AEC2s in infected tissue is reflected 297 
in the upregulation of markers of these cell types.  However, many of the genes and pathways 298 
that have altered expression in JSRV infection have not been previously studied in OPA but are 299 
associated with important aspects of OPA pathogenesis including tumor pathways and local 300 
immune responses.  Collectively, this study provides important new information on the host 301 
response to JSRV infection that will be valuable for studies of OPA directly and for exploitation 302 
of the sheep disease as a lung cancer model.   303 
 304 
In this study, we utilized tissue from experimentally-infected SPF lambs in order to avoid the 305 
potential confounding effects of additional respiratory infections that commonly occur in natural 306 
cases of OPA (1).  For welfare reasons, experimentally-infected lambs must be culled when 307 
respiratory signs first appear and therefore the tissues studied represent an early stage of disease 308 
compared to the advanced stage of natural cases of OPA.  We used sections of total lung tissue 309 
because we were interested in analyzing the gene expression of the whole infected tissue.  A 310 
consequence of this approach is that the experimental OPA samples contained a greater 311 
proportion of histologically normal lung tissue than tumor tissue.  We anticipated that this excess 312 
of ‘healthy’ tissue would reduce the sensitivity of our study to detect differentially expressed 313 
genes, in particular down-regulated genes (37, 38).  This would appear to be the case as only four 314 
genes were found to have downregulated expression by more than two-fold in OPA.  315 
Nevertheless, while this approach is expected to underestimate the fold-changes of differentially-316 
expressed genes it should still provide the correct order of significance.  Future work will focus 317 
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on analysis of gene expression in specific cell types such as tumor cells and myeloid cells, which 318 
should increase the sensitivity of detection of differentially expressed genes in those cell subsets. 319 
 320 
Oncogenic signaling pathways in OPA. 321 
The mechanisms involved in JSRV Env-mediated tumorigenesis are not completely understood 322 
and multiple cellular pathways appear to be activated (15, 17, 18).  Several studies have shown 323 
that Env expression leads to activation of the PI3K/Akt and MAPK/ERK1/2 signaling pathways 324 
(14, 18, 39, 40), while additional pathways including EGFR and Wnt signaling may also play a 325 
role (15, 19, 41, 42).  The RNA-Seq data provided evidence supporting a variety of changes in 326 
gene expression related to carcinogenesis, including increased expression of several ligands of 327 
EGFR and other ERBB family receptors and upregulation of a variety of ligands and receptors 328 
related to Wnt signaling in JSRV-infected lung tissue.   329 
 330 
Interestingly, the major components of the PI3K/Akt and MAPK/ERK1/2 signaling pathways 331 
were not significantly upregulated.  Indeed, DAVID pathway analysis reported that both of these 332 
pathways were downregulated in OPA.  There are several possible explanations for this apparent 333 
discrepancy.  For example, activation of the MAPK and PI3K/Akt pathways is mediated by 334 
protein phosphorylation cascades, which may not correspond directly to changes in transcription 335 
of those genes.  In addition, while previous studies have shown roles for Akt and ERK signaling 336 
in tumor cells or transfected cell lines, the RNA-Seq analysis presented here reflects global 337 
transcriptional changes within the whole tissue, which comprises multiple cell types.  Most 338 
importantly, the MAPK and PI3K/Akt pathways are involved in many cellular processes in 339 
addition to oncogenesis, including immune responses (43, 44), and the list of genes that DAVID 340 
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and similar tools uses for identifying members of a pathway is very broad.  For example, several 341 
of the genes identified by DAVID as involved in the PI3K/Akt and MEK/ERK1/2 pathways are 342 
involved in immune responses (e.g., TLR2, CSF1, COL6A3, NFKB1 and TNF), which is 343 
consistent with the other changes in immune and inflammatory responses observed in our study.  344 
 345 
An important novel finding in our study was the activation of AGR2 in OPA tumor cells (Fig. 4).  346 
AGR2 is a protein disulfide isomerase localized in the endoplasmic reticulum in normal cells, 347 
but is upregulated in a variety of human adenocarcinomas where it may also be present in 348 
secreted and cell-surface-bound forms (45, 46).  AGR2 is associated with poor prognosis in 349 
several cancer types and appears to mediate its oncogenic effect through the regulation of other 350 
genes including TP53 (47) and AREG (30) and through extracellular functions such as promoting 351 
angiogenesis and extracellular matrix remodeling (46, 48).  In humans, AGR2 expression is 352 
significantly higher in LUAD than in LUSC (49).  The activation of AREG by AGR2 has been 353 
shown to be dependent on the Hippo pathway effector protein YAP1 in human adenocarcinoma 354 
cell lines (30).  Consistent with this, IHC analysis confirmed the presence of nuclear YAP1 in 355 
OPA tumor cells (Fig. 5), suggesting a possible role for Hippo signaling in OPA pathogenesis.  356 
While further work is required, the transcriptional upregulation of AGR2, EGFR ligands and 357 
other oncogenic factors identified by RNA-Seq provides new opportunities for understanding 358 
oncogenic signaling in OPA.  In turn, OPA provides a model for studying the function of these 359 
pathways in a naturally occurring tumor, particularly at the early stages of tumorigenesis. 360 
 361 
Local immune responses in OPA-affected lung tissue. 362 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
17 
The absence of a significant adaptive immune response to JSRV in sheep is commonly attributed 363 
to enJSRV expression in the fetal thymus during immune development, which is proposed to 364 
lead to immune tolerance through the deletion of T-lymphocytes that recognize the closely 365 
related JSRV proteins (5).  The results of the RNA-Seq analysis suggest that JSRV infection 366 
induces substantial immunological changes in lung tissue, including altered expression of 367 
numerous cytokines, chemokines and complement factors together with an increase in 368 
macrophages associated with tumor foci.  These changes suggest that local immune-modulatory 369 
mechanisms active within the OPA-affected lung might also suppress the immune response to 370 
JSRV. 371 
 372 
The activation of complement factors and complement regulatory factors in OPA is consistent 373 
with a previous microarray analysis of gene expression in a mouse model of JSRV Env-mediated 374 
transformation that also found evidence of complement upregulation (50).  Complement has 375 
been shown previously to inhibit infection of a number of viruses including retroviruses (51), 376 
and studies on human and murine cancers have established roles for complement in modulating 377 
tumor growth (52-55).  Therefore, complement might also play an immunomodulatory role in 378 
OPA tumors.  379 
 380 
Macrophages exhibit significant functional plasticity (56, 57) and gene expression studies 381 
suggest the existence of numerous subpopulations of macrophages, including some with 382 
important roles in cancer (56-58).  In addition, studies of mouse and human cancers have shown 383 
that macrophages and other myeloid cells in the tumor microenvironment are essential for tumor 384 
survival and metastasis (58, 59).  Tumor-associated macrophages are also abundant in OPA (7) 385 
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but the phenotype of these cells and their functional significance is unclear.  In experimentally-386 
induced OPA, we identified changes in the expression of 198 genes related to macrophage 387 
function, including genes previously associated with an inflammatory or immunoregulatory 388 
phenotype.  Interestingly, the expression of macrophage markers in OPA appears to vary 389 
depending on their location within the affected tissue, with cells on the periphery of tumor foci 390 
being CD68-positive and cells within the tumor being CD163-positive and CD68-negative (Fig. 391 
8).  CD163 is regarded as a reliable marker for immunomodulatory macrophages that are 392 
associated with poor prognosis in human tumors (60, 61).  The positive CD163 labeling of OPA-393 
associated macrophages therefore suggests that these cells might also promote tumor growth in 394 
OPA.   395 
 396 
In contrast, the transcriptome analysis provided little evidence to support a strong adaptive 397 
immune response in OPA.  For example, there was no activation of T-cell markers other than a 398 
modest but statistically significant increase in markers of Tregs (FOXP3 and CD44; although 399 
note that CD44 is also a marker for macrophages and AEC2s).  In addition, there was no 400 
evidence of substantial activation of type 1 interferon responses in OPA, whereas IFNG 401 
expression was not significantly changed in JSRV-infected lambs but was upregulated in natural 402 
cases studied by RT-qPCR (Fig. 6).  This is possibly due to the presence of concurrent bacterial 403 
infections in the natural cases but demonstrates an important difference between early 404 
experimental OPA and advanced natural cases.    405 
 406 
Collectively, the gene expression data reported here suggest the presence of an 407 
immunomodulatory environment within the OPA lung, which has the potential to suppress the 408 
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immune response to JSRV and tumor cells and to actively promote tumor growth.  A more 409 
detailed quantitative analysis of the role of tumor-associated myeloid cells, complement and 410 
Tregs in OPA is necessary to determine their contribution to tumor growth and development of 411 
clinical disease.  This could reveal insights into the relevance of the tumor microenvironment to 412 
the apparent immune tolerance of sheep to JSRV and may inform the design of vaccine strategies 413 
for controlling OPA.  414 
 415 
Comparison of the transcriptomes of OPA and human LUAD. 416 
As OPA is frequently cited as an animal model for human lung adenocarcinoma, we compared 417 
the transcriptome data from OPA with published data on human lung tumors in an attempt to 418 
identify the similarities and differences between the diseases in the two species. The results 419 
indicate closer similarity of the transcriptome of OPA with human LUAD than with LUSC and 420 
in particular with early (stages I and II) compared to more advanced disease (stages III and IV) 421 
(Fig. 9A, C; Supplementary Dataset S6).  This is consistent with the histological appearance of 422 
OPA which resembles a minimally invasive adenocarcinoma in its early stages (2, 22, 24, 25).  It 423 
would be interesting in future studies to compare gene expression in the early stage of disease 424 
studied here with that of more advanced OPA. 425 
 426 
Many genes showed a common pattern of differential expression in LUAD, LUSC and OPA but 427 
there were also many that did not.  Some of these reflect differences between LUAD and LUSC 428 
and highlight the diversity of gene expression in the different tumor types.  For example, 142 429 
genes were upregulated in both OPA and stage I LUAD but downregulated or not significantly 430 
altered in stage I LUSC.  Notably, this includes AGR2 and the Wnt pathway effector protein 431 
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beta-catenin.  Similarly, 86 genes were upregulated in OPA and stage I LUSC but not 432 
upregulated in stage I LUAD.  In addition, there were 134 genes upregulated in OPA that were 433 
downregulated in both LUAD and LUSC.  These include SFTPC and LAMP3 which are known 434 
markers of AEC2s in sheep and humans (62).  LAMP3 has been detected in OPA previously but 435 
is rarely expressed in human tumors except in bronchioloalveolar-adenocarcinoma (lepidic-436 
prominent adenocarcinoma-in-situ) (62), which were not represented in the LUAD cases in the 437 
TGCA data studied.  Interestingly, the upregulation of complement factors observed in OPA was 438 
not evident in either LUAD or LUSC and several other key immune response related genes, such 439 
as TLR10, CCL4, CCL26, CD8A, CD8B, TNF and IDO1, were specifically downregulated in 440 
OPA but not in human LUAD, suggesting that innate immune responses in the sheep and human 441 
diseases may differ in important ways.  Collectively, this analysis provides support for the 442 
similarity of experimental OPA to early stage LUAD but highlights that there remain many 443 
differences between the sheep and human diseases.  444 
 445 
In summary, the findings from this first large-scale analysis of host gene expression in OPA 446 
significantly increase our understanding of the disease pathogenesis at a transcriptional level and 447 
will inform future research directed at improving OPA disease control.  Moreover, the 448 
interspecies comparative data between sheep and humans provide additional support for the use 449 
of OPA as a model for early stages of LUAD, particularly non-invasive forms.  Finally, a deeper 450 
understanding of the pathological changes of early tumors could help to identify novel 451 
biomarkers for the early detection of cancer lesions in both species.   452 
 453 
MATERIALS AND METHODS 454 
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 455 
Animals and tissues. 456 
Tissues were available from a previous study in which four specific pathogen free (SPF) lambs 457 
were inoculated through intra-tracheal injection with JSRV at six days of age (9).  Four 458 
additional lambs received cell culture supernatant (mock-infected control).  Each group 459 
contained one female and three male lambs.  All lambs were caesarean-derived and housed in 460 
SPF conditions to minimize the risk of acquiring additional respiratory infections.  Once the 461 
clinical signs of respiratory disease were apparent in the JSRV-infected animals (66d, 71d and 462 
85d (n=2) post inoculation), lambs were culled.  Each time a JSRV-infected lamb was 463 
euthanized, a healthy animal from the mock-infected control group was culled to provide age and 464 
sex-matched control tissues.  Tissues were collected from 24 locations in each lung and stored in 465 
liquid nitrogen for RNA extraction and in 10% buffered formalin for IHC.  To study tissues from 466 
animals with natural disease, lung samples were taken from four farm-raised adult sheep in the 467 
advanced stages of clinical OPA and four clinically healthy adult sheep.  Cases were selected 468 
which had no gross appearance of bacterial or parasitic infection.  All protocols involving animal 469 
handling and the use of post-mortem material were approved by the Animal Welfare and Ethical 470 
Review Body of Moredun Research Institute in accordance with the U.K. Animals (Scientific 471 
Procedures) Act 1986. 472 
  473 
RNA extraction and sequencing. 474 
For RNA-Seq, RNA was extracted from frozen tissue samples from seven distinct sites of the 475 
lungs of each animal and pooled in equal amounts.  Total RNA from cryosectioned tissue was 476 
extracted using an RNeasy mini kit (Qiagen) according to the manufacturer’s instructions.  RNA 477 
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concentration and purity were measured (ND-1000 Nanodrop) and RNA integrity was confirmed 478 
(Agilent RNA 6000 Nano kit with Agilent 2100 Bioanalyzer).  All samples had an RNA integrity 479 
number (RIN) greater than 8.0.  Prior to sequencing, frozen lung sections derived from the same 480 
lung sites were examined by histology, which confirmed the presence of OPA tumor lesions in 481 
the JSRV-infected animals and the absence of lesions in the mock-infected negative controls.  482 
Total RNA was processed (TruSeq RNA Library kit) to generate cDNA libraries according to the 483 
manufacturer’s instructions and subsequently sequenced with an Illumina HiSeq2000 instrument 484 
using 100 bp paired-end sequencing (Edinburgh Genomics, University of Edinburgh, UK). 485 
 486 
Processing of next generation sequencing data and differential expression analysis. 487 
Raw sequencing reads were processed to remove adaptors and poor-quality sequences (Q25 and 488 
below) using Cutadapt 1.10 (63).  Non-redundant reads were then mapped to the sheep 489 
(Oar_v3.1, Ensembl FTP release 74) and JSRV (GenBank accession AF105220.1) genomes 490 
using HISAT2-2.0.4 (64).  The quantification of gene expression was calculated using HTSeq-491 
counts (65).  Transcripts with fewer than 100 total reads across the eight samples were excluded.  492 
The sheep annotation (GTF) was obtained from Ensembl (Oar_v3.1.79).  The virus and sheep 493 
gene counts were imported into the edgeR package (66) and counts were normalized using a 494 
trimmed mean of M-values (67) and fitted to a negative binomial generalized log-linear model to 495 
calculate the dispersion factor for each gene (68).  Differentially expressed genes were then 496 
identified by applying a FDR cutoff of 0.05 (69).  Principal component analysis of normalized 497 
counts was performed using only sheep gene expression (i.e., counts from viral genes were 498 
removed) in order to see the variation between the two groups.   499 
 500 
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Gene function annotation and pathway analysis. 501 
Identification of enriched KEGG pathways in the upregulated and downregulated gene lists was 502 
performed with DAVID (Database for Annotation, Visualization, and Integrated Discovery) v6.8 503 
(26).  Pathway analysis was performed using Ingenuity Pathway Analysis (IPA), version 01-04 504 
(27) to infer the functional roles and relationships of the differentially expressed genes based on 505 
the log2 fold-change value of each gene. 506 
 507 
Comparative analysis with human datasets.  508 
To compare significantly-expressed genes in JSRV-infected lung with data from human NSCLC, 509 
HTSeq-counts from RNA-Seq data for LUAD and LUSC were obtained from the GDC portal 510 
(portal.gdc.cancer.gov).  57 LUAD and 49 LUSC patients were selected for which corresponding 511 
normal and tumor data were available.  Differentially expressed genes in human tumors were 512 
identified using the edgeR pipeline as for the sheep data.  The list of differentially expressed 513 
genes in human data was filtered for only those that have an orthologous gene in sheep 514 
(identified using Ensembl Biomart) and were differentially expressed in sheep.  The comparison 515 
of expression of these short-listed genes was made using the correlation between expression 516 
profile (i.e., fold-change) in humans and in sheep.  The gene lists obtained are presented in 517 
Supplementary Data S5.    518 
 519 
RT-qPCR 520 
RT-qPCR was performed according to MIQE recommendations (70).  Primers and probes for 521 
reference and target genes are summarized in Table 2.  RT-qPCR was performed using an ABI 522 
7000 Sequence Detection System in 96-well plates (Applied Biosystems) with either TaqMan 523 
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one-step RT-PCR reagents (Applied Biosystems; JSRV, CCL2) or Power SYBR-Green RNA-to 524 
CT 1-Step Kit (Applied Biosystems; all other target genes).  Each sample (5 sites per animal) 525 
was tested in duplicate using 100 ng of RNA in a 20 μl final reaction volume.  All experiments 526 
with SYBR-green included a melting curve analysis to confirm the specificity of the amplicons 527 
(95°C for 15 s, 60°C for 20 s and 95°C for 15 s).  Standard curves constructed from 10-fold 528 
serial dilutions of positive control RNA were used to determine efficiency and replicate quality 529 
(R2) of each primer set.  In addition, the level of gene expression in experimental samples was 530 
ensured to lay within the limits of the standard curve.  For comparison of RNA transcription 531 
levels between samples, results from the RT-qPCR experiments were normalized to two 532 
reference genes, succinate dehydrogenase (SDHA) and β-actin (ACTB) (pre-determined as 533 
stable reference genes using geNORM (71)).  Statistical analysis for quantitative PCR was 534 
performed by group-wise comparison based on PCR efficiencies and the mean crossing point 535 
deviation between the sample and control group using Relative Expression Software Tool 536 
(REST) (72).  537 
 538 
Immunohistochemistry and immunofluorescence 539 
Tissue sections were processed routinely through graded alcohols, embedded in paraffin-wax and 540 
IHC was performed on sections (4 µm) mounted on charged glass microscope slides as 541 
previously described (9).  The dilutions and sources of the primary antibodies used are described 542 
in Table 3. Isotype controls were used in semi-serial tissue sections for each primary antibody.  543 
Additionally, the primary antibody was omitted to check for nonspecific labeling by the 544 
secondary antibody or the visualization system.  Images for bright-field microscopy were 545 
examined using an Olympus BX51 microscope, and photographs were captured with an 546 
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Olympus DP70 camera with analySIS software (Soft Imaging System GmbH, Munster, 547 
Germany).  Immunofluorescence was performed as previously described (9) using primary 548 
antibodies to AGR2 (1:100, Abcam ab76473), and JSRV Env (1:50) (73) with appropriate 549 
secondary antibodies conjugated with Alexa-488 (A11008, Molecular Probes) or Alexa-555 550 
(A31622, Molecular Probes).  Slides were mounted with medium containing 4′,6-diamidino-2-551 
phenylindole (DAPI) (Vectashield, Vector Laboratories).  Images were analyzed using a Zeiss 552 
Axio Imager 2 fluorescence microscope with Apotome, and AxioVision Software.  553 
 554 
Data Availability 555 
The raw RNA-Seq reads (fastq data) of each sample are present in the European Nucleotide 556 
Archive with the accession ID PRJEB27638. 557 
 558 
ACKNOWLEDGEMENTS 559 
We thank Edinburgh Genomics (https://genomics.ed.ac.uk/) for conducting the RNA-Seq 560 
experiments and Sarah Wootton for providing the anti-JSRV SU antibody.  We thank staff of the 561 
Moredun Research Institute Clinical Division for exceptional animal care and the farmers who 562 
support our work through the donation of OPA-affected sheep.  This project was supported by 563 
the Biotechnology and Biological Sciences Research Council (BB/L009129/1, BB/L008505/1), 564 
including institute strategic program and national capability awards to The Roslin Institute 565 
(BB/P013740/1, BB/P013759/1, BB/P013732/1, BB/J004235/1, BB/J004243/1, 566 
BBS/E/D/20002173, BBS/E/D/20002174) and the Scottish Government Rural and Environment 567 
Science and Analytical Services Division (RESAS). 568 
  569 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
26 
REFERENCES 570 
1. De Las Heras M, González L, Sharp JM. 2003. Pathology of ovine pulmonary 571 
adenocarcinoma.  Curr Top Microbiol Immunol. 275:25-54. 572 
2. Griffiths DJ, Martineau HM, Cousens C. 2010. Pathology and pathogenesis of ovine 573 
pulmonary adenocarcinoma. J Comp Pathol 142:260-283. 574 
3. Cousens C, Thonur L, Imlach S, Crawford J, Sales J, Griffiths DJ. 2009. Jaagsiekte sheep 575 
retrovirus is present at high concentration in lung fluid produced by ovine pulmonary 576 
adenocarcinoma-affected sheep and can survive for several weeks at ambient 577 
temperatures. Res Vet Sci 87:154-156. 578 
4. Palmarini M, Sharp JM, de las Heras M, Fan H. 1999. Jaagsiekte sheep retrovirus is 579 
necessary and sufficient to induce a contagious lung cancer in sheep. J Virol 73:6964-580 
6972. 581 
5. Palmarini M, Mura M, Spencer TE. 2004. Endogenous betaretroviruses of sheep: 582 
teaching new lessons in retroviral interference and adaptation. J Gen Virol 85:1-13. 583 
6. Spencer TE, Mura M, Gray CA, Griebel PJ, Palmarini M. 2003. Receptor usage and fetal 584 
expression of ovine endogenous betaretroviruses: implications for coevolution of 585 
endogenous and exogenous retroviruses. J Virol 77:749-753. 586 
7. Summers C, Norval M, De Las Heras M, Gonzalez L, Sharp JM, Woods GM. 2005. An 587 
influx of macrophages is the predominant local immune response in ovine pulmonary 588 
adenocarcinoma. Vet Immunol Immunopathol 106:285-294. 589 
8. De las Heras M, de Martino A, Borobia M, Ortin A, Alvarez R, Borderias L, Gimenez-590 
Mas JA. 2014. Solitary tumours associated with Jaagsiekte retrovirus in sheep are 591 
heterogeneous and contain cells expressing markers identifying progenitor cells in lung 592 
repair. J Comp Pathol 150:138-147. 593 
9. Martineau HM, Cousens C, Imlach S, Dagleish MP, Griffiths DJ. 2011. Jaagsiekte sheep 594 
retrovirus infects multiple cell types in the ovine lung. J Virol 85:3341-3355. 595 
10. Murgia C, Caporale M, Ceesay O, Di Francesco G, Ferri N, Varasano V, de las Heras M, 596 
Palmarini M. 2011. Lung adenocarcinoma originates from retrovirus infection of 597 
proliferating type 2 pneumocytes during pulmonary post-natal development or tissue 598 
repair. PLoS Pathog 7:e1002014. 599 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
27 
11. Maeda N, Palmarini M, Murgia C, Fan H. 2001. Direct transformation of rodent 600 
fibroblasts by jaagsiekte sheep retrovirus DNA. Proc Natl Acad Sci U S A 98:4449-4454. 601 
12. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD. 602 
2001. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-603 
anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of 604 
which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98:4443-4438. 605 
13. Caporale M, Cousens C, Centorame P, Pinoni C, De las Heras M, Palmarini M. 2006. 606 
Expression of the jaagsiekte sheep retrovirus envelope glycoprotein is sufficient to induce 607 
lung tumors in sheep. J Virol 80:8030-8037. 608 
14. Cousens C, Maeda N, Murgia C, Dagleish MP, Palmarini M, Fan H. 2007. In vivo 609 
tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not 610 
full-length orfX open reading frame. Virology 367:413-421. 611 
15. Linnerth-Petrik NM, Santry LA, Yu DL, Wootton SK. 2012. Adeno-associated virus 612 
vector mediated expression of an oncogenic retroviral envelope protein induces lung 613 
adenocarcinomas in immunocompetent mice. PLoS One 7:e51400. 614 
16. Wootton SK, Halbert CL, Miller AD. 2005. Sheep retrovirus structural protein induces 615 
lung tumours. Nature 434:904-907. 616 
17. Hofacre A, Fan H. 2010. Jaagsiekte sheep retrovirus biology and oncogenesis. Viruses 617 
2:2618-2648. 618 
18. Liu SL, Miller AD. 2007. Oncogenic transformation by the jaagsiekte sheep retrovirus 619 
envelope protein. Oncogene 26:789-801. 620 
19. Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, Miller AD, Lerman 621 
MI. 2003. Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and 622 
mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc Natl Acad 623 
Sci U S A 100:4580-4585. 624 
20. Hsu T, Phung A, Choe K, Kim JW, Fan H. 2015. Role for a zinc finger protein (Zfp111) 625 
in transformation of 208F rat fibroblasts by jaagsiekte sheep retrovirus envelope protein. 626 
J Virol 89:10453-10466. 627 
21. Monot M, Erny A, Gineys B, Desloire S, Dolmazon C, Aublin-Gex A, Lotteau V, Archer 628 
F, Leroux C. 2015. Early steps of jaagsiekte sheep retrovirus-mediated cell 629 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
28 
transformation involve the interaction between Env and the RALBP1 cellular protein. J 630 
Virol 89:8462-8473. 631 
22. Youssef G, Wallace WA, Dagleish MP, Cousens C, Griffiths DJ. 2015. Ovine pulmonary 632 
adenocarcinoma: a large animal model for human lung cancer. ILAR J 56:99-115. 633 
23. Palmarini M, Fan H. 2001. Retrovirus-induced ovine pulmonary adenocarcinoma, an 634 
animal model for lung cancer. J Natl Cancer Inst 93:1603-1614. 635 
24. Mornex JF, Thivolet F, De las Heras M, Leroux C. 2003. Pathology of human 636 
bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr Top 637 
Microbiol Immunol 275:225-248. 638 
25. Perk K, Hod I. 1982. Sheep lung carcinoma: an endemic analogue of a sporadic human 639 
neoplasm. J Natl Cancer Inst 69:747-749. 640 
26. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of 641 
large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. 642 
27. Kramer A, Green J, Pollard J, Jr., Tugendreich S. 2014. Causal analysis approaches in 643 
Ingenuity Pathway Analysis. Bioinformatics 30:523-530. 644 
28. Gomes M, Archer F, Girard N, Gineys B, Dolmazon C, Bobet Erny A, Mornex JF, 645 
Leroux C. 2017. Blocked expression of key genes of the angiogenic pathway in JSRV-646 
induced pulmonary adenocarcinomas. Vet Res 48:76. 647 
29. Brychtova V, Mohtar A, Vojtesek B, Hupp TR. 2015. Mechanisms of anterior gradient-2 648 
regulation and function in cancer. Semin Cancer Biol 33:16-24. 649 
30. Dong A, Gupta A, Pai RK, Tun M, Lowe AW. 2011. The human adenocarcinoma-650 
associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-651 
activator YAP1 activation. J Biol Chem 286:18301-18310. 652 
31. Chung C, Kim T, Kim M, Kim M, Song H, Kim TS, Seo E, Lee SH, Kim H, Kim SK, 653 
Yoo G, Lee DH, Hwang DS, Kinashi T, Kim JM, Lim DS. 2013. Hippo-Foxa2 signaling 654 
pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc Natl 655 
Acad Sci U S A 110:7732-7737. 656 
32. Shaw AE, Hughes J, Gu Q, Behdenna A, Singer JB, Dennis T, Orton RJ, Varela M, 657 
Gifford RJ, Wilson SJ, Palmarini M. 2017. Fundamental properties of the mammalian 658 
innate immune system revealed by multispecies comparison of type I interferon 659 
responses. PLoS Biol 15:e2004086. 660 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
29 
33. Fulton RB, Meyerholz DK, Varga SM. 2010. Foxp3+ CD4 regulatory T cells limit 661 
pulmonary immunopathology by modulating the CD8 T cell response during respiratory 662 
syncytial virus infection. J Immunol 185:2382-2392. 663 
34. Sozmen M, Beytut E. 2012. An investigation of growth factors and lactoferrin in 664 
naturally occurring ovine pulmonary adenomatosis. J Comp Pathol 147:441-451. 665 
35. Komohara Y, Hirahara J, Horikawa T, Kawamura K, Kiyota E, Sakashita N, Araki N, 666 
Takeya M. 2006. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule 667 
associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 668 
54:763-771. 669 
36. Chang JT, Lee YM, Huang RS. 2015. The impact of the Cancer Genome Atlas on lung 670 
cancer. Transl Res 166:568-585. 671 
37. Kim HK, Kim J, Korolevich S, Choi IJ, Kim CH, Munroe DJ, Green JE. 2011. 672 
Distinctions in gastric cancer gene expression signatures derived from laser capture 673 
microdissection versus histologic macrodissection. BMC Med Genomics 4:48. 674 
38. Klee EW, Erdogan S, Tillmans L, Kosari F, Sun Z, Wigle DA, Yang P, Aubry MC, 675 
Vasmatzis G. 2009. Impact of sample acquisition and linear amplification on gene 676 
expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-677 
sampling versus bulk tissue-sampling. BMC Med Genomics 2:13. 678 
39. De Las Heras M, Ortin A, Benito A, Summers C, Ferrer LM, Sharp JM. 2006. In-situ 679 
demonstration of mitogen-activated protein kinase Erk 1/2 signalling pathway in 680 
contagious respiratory tumours of sheep and goats. J Comp Pathol 135:1-10. 681 
40. Cousens C, Alleaume C, Bijsmans E, Martineau HM, Finlayson J, Dagleish MP, Griffiths 682 
DJ. 2015. Jaagsiekte sheep retrovirus infection of lung slice cultures. Retrovirology 683 
12:31. 684 
41. Varela M, Golder M, Archer F, de las Heras M, Leroux C, Palmarini M. 2008. A large 685 
animal model to evaluate the effects of Hsp90 inhibitors for the treatment of lung 686 
adenocarcinoma. Virology 371:206-215. 687 
42. Vaughan AE, Halbert CL, Wootton SK, Miller AD. 2012. Lung cancer in mice induced 688 
by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem 689 
cells, but tumorigenicity does correlate with Wnt pathway activation. Mol Cancer Res 690 
10:86-95. 691 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
30 
43. Arthur JS, Ley SC. 2013. Mitogen-activated protein kinases in innate immunity. Nat Rev 692 
Immunol 13:679-692. 693 
44. Collins DC, Chenard-Poirier M, Lopez JS. 2018. The PI3K pathway at the crossroads of 694 
cancer and the immune system: strategies for next generation immunotherapy 695 
combinations. Curr Cancer Drug Targets 18:355-364. 696 
45. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue 697 
CA, Brentnall TA, Bronner MP, Feakins RM, Timms JF, Brennan C, Lemoine NR, 698 
Crnogorac-Jurcevic T. 2011. AGR2 is a novel surface antigen that promotes the 699 
dissemination of pancreatic cancer cells through regulation of cathepsins B and D. 700 
Cancer Res 71:7091-7102. 701 
46. Fessart D, Domblides C, Avril T, Eriksson LA, Begueret H, Pineau R, Malrieux C, 702 
Dugot-Senant N, Lucchesi C, Chevet E, Delom F. 2016. Secretion of protein disulphide 703 
isomerase AGR2 confers tumorigenic properties. Elife 5:e13887. 704 
47. Hrstka R, Bouchalova P, Michalova E, Matoulkova E, Muller P, Coates PJ, Vojtesek B. 705 
2016. AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-706 
mediated regulatory pathway. Mol Oncol 10:652-662. 707 
48. Guo H, Zhu Q, Yu X, Merugu SB, Mangukiya HB, Smith N, Li Z, Zhang B, Negi H, 708 
Rong R, Cheng K, Wu Z, Li D. 2017. Tumor-secreted anterior gradient-2 binds to VEGF 709 
and FGF2 and enhances their activities by promoting their homodimerization. Oncogene 710 
36:5098-5109. 711 
49. Pizzi M, Fassan M, Balistreri M, Galligioni A, Rea F, Rugge M. 2012. Anterior gradient 712 
2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol 20:31-713 
36. 714 
50. Chang HW, Lin Z-M, Wu M-J, Wang L-Y, Chow Y-H, Jiang SS, Ch'ang H-J, Chang 715 
VHS. 2017. Characterization of a transgenic mouse model exhibiting spontaneous lung 716 
adenocarcinomas with a metastatic phenotype. PLoS One 12:e0175586. 717 
51. Agrawal P, Nawadkar R, Ojha H, Kumar J, Sahu A. 2017. Complement evasion 718 
strategies of viruses: an overview. Front Microbiol 8:1117. 719 
52. Reis ES, Mastellos DC, Ricklin D, Mantovani A, Lambris JD. 2018. Complement in 720 
cancer: untangling an intricate relationship. Nat Rev Immunol 18:5-18. 721 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
31 
53. Okroj M, Hsu Y-F, Ajona D, Pio R, Blom AM. 2008. Non-small cell lung cancer cells 722 
produce a functional set of complement factor I and its soluble cofactors. Molecular 723 
Immunol 45:169-179. 724 
54. Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, 725 
Gerard C, Coukos G, Lambris JD. 2008. Modulation of the antitumor immune response 726 
by complement. Nat Immunol 9:1225-1235. 727 
55. Medler TR, Murugan D, Horton W, Kumar S, Cotechini T, Forsyth AM, Leyshock P, 728 
Leitenberger JJ, Kulesz-Martin M, Margolin AA, Werb Z, Coussens LM. 2018. 729 
Complement C5a fosters squamous carcinogenesis and limits T cell response to 730 
chemotherapy. Cancer Cell 34:561-578 e6. 731 
56. Qian B, Pollard JW. 2010. Macrophage diversity enhances tumor progression and 732 
metastasis. Cell 141:39-51. 733 
57. Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, Krishnan I, 734 
Maroni G, Meyerovitz CV, Kerwin CM, Choi S, Richards WG, De Rienzo A, Tenen DG, 735 
Bueno R, Levantini E, Pittet MJ, Klein AM. 2019. Single-cell transcriptomics of human 736 
and mouse lung cancers reveals conserved myeloid populations across individuals and 737 
species. Immunity 50: 1317-1334. 738 
58. Kitamura T, Qian BZ, Pollard JW. 2015. Immune cell promotion of metastasis. Nat Rev 739 
Immunol 15:73-86. 740 
59. Lewis CE, Pollard JW. 2006. Distinct role of macrophages in different tumor 741 
microenvironments. Cancer Res 66:605-612. 742 
60. Medrek C, Ponten F, Jirstrom K, Leandersson K. 2012. The presence of tumor associated 743 
macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC 744 
Cancer 12:306. 745 
61. Yang L, Wang F, Wang L, Huang L, Wang J, Zhang B, Zhang Y. 2015. CD163+ tumor-746 
associated macrophage is a prognostic biomarker and is associated with therapeutic effect 747 
on malignant pleural effusion of lung cancer patients. Oncotarget 6:10592-10603. 748 
62. Salaun B, de Saint-Vis B, Pacheco N, Pacheco Y, Riesler A, Isaac S, Leroux C, Clair-749 
Moninot V, Pin JJ, Griffith J, Treilleux I, Goddard S, Davoust J, Kleijmeer M, Lebecque 750 
S. 2004. CD208/dendritic cell-lysosomal associated membrane protein is a marker of 751 
normal and transformed type II pneumocytes. Am J Pathol 164:861-871. 752 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
32 
63. Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing 753 
reads. EMBnetjournal 17:10-12. 754 
64. Kim D, Langmead B, Salzberg SL. 2015. HISAT: a fast spliced aligner with low memory 755 
requirements. Nat Methods 12:357-360. 756 
65. Anders S, Pyl PT, Huber W. 2015. HTSeq--a Python framework to work with high-757 
throughput sequencing data. Bioinformatics 31:166-169. 758 
66. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for 759 
differential expression analysis of digital gene expression data. Bioinformatics 26:139-760 
140. 761 
67. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential 762 
expression analysis of RNA-seq data. Genome Biology 11:R25-R25. 763 
68. McCarthy DJ, Chen Y, Smyth GK. 2012. Differential expression analysis of multifactor 764 
RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40:4288-765 
4297. 766 
69. Lun AT, Chen Y, Smyth GK. 2016. It's DE-licious: a recipe for differential expression 767 
analyses of RNA-seq experiments using quasi-likelihood methods in edgeR. Methods 768 
Mol Biol 1418:391-416. 769 
70. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, 770 
Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. 2009. The MIQE guidelines: 771 
minimum information for publication of quantitative real-time PCR experiments. Clin 772 
Chem 55:611-622. 773 
71. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 774 
2002. Accurate normalization of real-time quantitative RT-PCR data by geometric 775 
averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. 776 
72. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for 777 
group-wise comparison and statistical analysis of relative expression results in real-time 778 
PCR. Nucleic Acids Res 30:e36. 779 
73. Wootton SK, Metzger MJ, Hudkins KL, Alpers CE, York D, DeMartini JC, Miller AD. 780 
2006. Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus 781 
(JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology 3:94. 782 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
33 
74. Garcia-Crespo D, Juste RA, Hurtado A. 2006. Differential gene expression in central 783 
nervous system tissues of sheep with natural scrapie. Brain Res 1073-1074:88-92. 784 
75. Li H, Cunha CW, Davies CJ, Gailbreath KL, Knowles DP, Oaks JL, Taus NS. 2008. 785 
Ovine herpesvirus 2 replicates initially in the lung of experimentally infected sheep. J 786 
Gen Virol 89:1699-1708. 787 
76. Budhia S, Haring LF, McConnell I, Blacklaws BA. 2006. Quantitation of ovine cytokine 788 
mRNA by real-time RT-PCR. J Immunol Methods 309:160-172. 789 
77. McNeilly TN, Baker A, Brown JK, Collie D, Maclachlan G, Rhind SM, Harkiss GD. 790 
2008. Role of alveolar macrophages in respiratory transmission of visna/maedi virus. J 791 
Virol 82:1526-1536. 792 
78. Leutenegger CM, Alluwaimi AM, Smith WL, Perani L, Cullor JS. 2000. Quantitation of 793 
bovine cytokine mRNA in milk cells of healthy cattle by real-time TaqMan polymerase 794 
chain reaction. Vet Immunol Immunopathol 77:275-287. 795 
79. Kawashima K, Meyerholz DK, Gallup JM, Grubor B, Lazic T, Lehmkuhl HD, 796 
Ackermann MR. 2006. Differential expression of ovine innate immune genes by preterm 797 
and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol 798 
19:316-323. 799 
80. Dunphy J, Horvath A, Barcham G, Balic A, Bischof R, Meeusen E. 2001. Isolation, 800 
characterisation and expression of mRNAs encoding the ovine CC chemokines, 801 
monocyte chemoattractant protein (MCP)-1alpha and -2. Vet Immunol Immunopathol 802 
82:153-164. 803 
81. Clark EL, Bush SJ, McCulloch MEB, Farquhar IL, Young R, Lefevre L, Pridans C, 804 
Tsang HG, Wu C, Afrasiabi C, Watson M, Whitelaw CB, Freeman TC, Summers KM, 805 
Archibald AL, Hume DA. 2017. A high resolution atlas of gene expression in the 806 
domestic sheep (Ovis aries). PLoS Genet 13:e1006997. 807 
  808 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
34 
 809 
Table 1   Read mapping statistics 810 
 811 
 812 
 813 
a
 Lamb ID indicates the infection status, sex (male (M) or female (F)) and days post-inoculation 814 
when culled. 815 
b
 Reads mapping to the JSRV genome represented 0.09 – 0.41% of total reads in the four 816 
infected lambs. A small number of reads mapping to JSRV (49 – 128 per sample) were also 817 
detected in the tissue from mock-infected control lambs.  All of these reads mapped to regions of 818 
very high similarity between JSRV and enJSRV (data not shown) and so can be attributed to the 819 
transcription of endogenous viruses in the samples studied. 820 
 Lamb ID 
a
 
  
Infected 
1M_66days 
Infected 
2F_85days 
Infected 
3M_71days 
Infected 
4M_85days 
Control 
5M_66days 
Control 
6M_85days 
Control 
7M_71days 
Control 
8F_85days 
Total reads 64,879,262 72,907,048 84,205,226 68,631,006 60,417,140 69,875,636 64,020,136 72,061,316 
Total quality 
trimmed 
63,766,561 71,678,589 82,667,841 67,438,835 59,431,332 68,705,449 62,964,748 70,830,855 
Quality  
trimmed (%) 
98.28% 98.32% 98.17% 98.26% 98.37% 98.33% 98.35% 98.29% 
Total uniquely 
mapped 
51,720,272 58,431,025 67,009,475 55,039,775 48,778,008 55,995,176 51,447,365 58,063,922 
Uniquely 
mapped (%)  
79.72% 80.14% 79.58% 80.20% 80.74% 80.14% 80.36% 80.58% 
Viral reads 109,952 68,763 342,032 196,608 54
b 62b 128b 49b 
Viral reads (%) 0.17% 0.09% 0.41% 0.29% 0.00% 0.00% 0.00% 0.00% 
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 821 
Table 2 Primers and probes used in this study 822 
Target
a
 Primer sequences (5’-3’) 
Conc. 
(nM) 
Size 
(bp) 
GenBank Accession 
No. (Reference) 
ACTB 
F: CTGAGCGCAAGTACTCCGTGT 
R: GCATTTGCGGTGGACGAT 
300 
300 
125 NM_001009784 (74) 
SDHA 
F: CATCCACTACATGACGGAGCA 
R: ATCTTGCCATCTTCAGTTCTGCTA 
200 
200 
90 AY970969 (74) 
IFN- 
F: GCACTGGATCAGCAGCTCACTG 
R: CTCAAGACTTCTGCTCTGACAACCT 
200 
200 
188 AY 802984 (75) 
IFN- 
F: TTCTTGAACGGCAGCTCTGAG 
R: TGGCGACAGGTCATTCATCA 
300 
300 
127 X52640 (76) 
CSF2 
F: GATGGATGAAACAGTAGAAGTCG 
R: CAGCAGTCAAAGGGAATGAT 
500 
500 
261 NM_001009805 (77) 
TGF-1 
F: GAACTGCTGTGTTCGTCAGC 
R: GGTTGTGCTGGTTGTACAGG 
500 
500 
169 NM_001009400 (77) 
TNF- 
F: GCCCTGGTACGAACCCATCTA 
R: CGGCAGGTTGATCTCAGCAC 
200 
200 
82 NM_001024860 (75) 
IL-1 
F: CCTAACTGGTACATCAGCACTTCTCA 
R:TCCATTCTGAAGTCAGTTATATCCTG 
200 
200 
95 NM_001009465 (75) 
IL-6 
F: TCCAGAACGAGTTTGAGG 
R: CATCCGAATAGCTCTCAG 
500 
500 
236 
NM_ 001009392 
(77) 
IL-8 
F: ACTGCGAAAATTCAGAAATCATTGTTA 
R: CTTCAAAAATGCCTGCACAACCTTC 
500 
500 
53 S74436 (78) 
IL-10 
F: AGCAAGGCGGTGGAGCAG 
R: GATGAAGATGTCAAACTCACTCATGG 
200 
200 
90 NM_001009327 (75) 
IL-18 
F: ACTGTTCAGATAATGCACCCCAG 
R: TTCTTACACTGCACAGAGATGGTTAC 
200 
200 
100 NM_001009263 (75) 
CCL2 
F: GCTGTGATTTTCAAGACCATCCT 
R: GGCGTCCTGGACCCATT 
Probe: AAAGAGTTTTGTGCAGACCCCAACC 
900 
400 
900 
72 DY503036 (79, 80) 
 823 
a 
Amplification conditions were 30 min 45°C, 10 min 95°C, 40 cycles of (15s  95°C, 1 min 60 824 
°C), except for CSF2 (30 min 45°C, 10 min 95°C, 40 cycles of (20s 94°C, 30s 57°C, 30s 72°C)), 825 
CXCL8 (30 min 45°C, 10 min 95°C,  40 cycles of (20s 94°C, 30s 55°C, 30s 72°C)), TGF-beta 826 
(30 min 45°C, 10 min 95°C, 40 cycles of (20s 94°C, 30s 55°C, 30s 72°C)), IL-6 (30 min 45°C, 827 
10 min 95°C, 40 cycles of (20s 94°C, 30s 52°C, 30s 72°C)) and CCL2 (30 min 45°C, 10 min 828 
95°C, 40 cycles of (20s 95°C, 30s 58°C, 30s 60°C)). 829 
  830 
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Table 3 Summary of antibodies used for IHC 831 
 832 
 
Target Antigen 
IHC 
Dilution 
Antibody 
type
a
 
 
Source 
JSRV Env (SU) 1/200 Mouse mab
 
(73) 
AGR2 1/200  Rabbit mab Abcam, ab134167 
AREG 1/200 Rabbit mab Abcam, ab224350 
MST1/2 1/5000 Rabbit pab
 
Abcam, ab87322 
LATS1/2 1/2000 Rabbit pab Abcam, ab70565 
Total YAP1 1/100 Rabbit mab Abcam, ab52771 
Phosphorylated (s127) YAP1 1/300 Rabbit pab Abcam, ab76252 
CD68 1/150 Mouse mab DAKO, M0718 
CD163 1/200 Mouse mab Bio-rad, MCA1853 
LGMN 1/400 Mouse mab Abcam, ab125286 
HIF1A 1/50 Mouse mab ThermoFisher MA1-16511 
 833 
a
mab: monoclonal, pab; polyclonal 834 
  835 
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FIGURE LEGENDS 836 
 837 
Figure 1. Host gene expression is modified in JSRV-infected lung tissue.  838 
A. Principal component analysis was performed using read counts from JSRV-infected and 839 
mock-infected (control) lambs for 15,149 genes mapping to the sheep genome.  Each circle 840 
represents a mock-infected lamb and each triangle indicates a JSRV-infected lamb. The values 841 
on each axis (PC1 and PC2) represent the percentage of variance explained by each component. 842 
The principal component 1 (PC1) separates the infected and mock samples into two clusters with 843 
the highest variance of 63%.  Within these clusters, there is greater variance in the JSRV-844 
infected sheep than the mock-infected sheep and this likely corresponds to the proportion of 845 
tumor-affected tissue in the samples.  For example, the lamb ‘Infected_F_85days’ is the closest 846 
to the mock-infected cluster and had the lowest proportion of reads mapping to JSRV (see Table 847 
1), while the samples furthest from the mock-infected animals had the highest proportion of viral 848 
reads.  B. The gene expression data visualized as a 2D scatter plot of the log2 ratio of expression 849 
values between infected and mock-infected tissue (i.e., the fold-change) versus the mean 850 
expression across all samples.  Each dot represents one gene and the red color indicates the 1,971 851 
genes identified as differentially expressed between the infected group and mock-infected 852 
controls using a false discovery rate (FDR) < 0.05.  C. Hierarchical clustering based on 853 
normalized gene counts of differentially expressed genes in samples derived from JSRV-treated 854 
and mock-infected lambs (1237 were upregulated and 734 downregulated).  D. Hierarchical 855 
clustering of the 25 most significantly upregulated and downregulated genes.  856 
 857 
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Figure 2. Main Diseases and Biofunctions associated with differentially expressed genes in 858 
JSRV-infected sheep lung.   859 
The figure shows the Biofunction enrichment profiles identified by Ingenuity Pathway Analysis, 860 
plotted by relative statistical significance. Significance values were calculated based on a right-861 
tailed Fisher's exact test and the -log(p-value) is displayed on the horizontal axis of the bar chart. 862 
The taller the bar, the more significant the pathway effect. 863 
 864 
Figure 3. Mechanistic network analysis predicted by Ingenuity Pathway Analysis. 865 
The figure shows mechanistic network analysis by IPA of genes differentially expressed in 866 
experimentally-induced OPA compared to mock-infected lung. A. Neovasculization network. B. 867 
Network for cell viability and tumor growth. The regulators are colored by their predicted 868 
activation state: activated (orange) or inhibited (blue). Darker colors indicate higher scores. The 869 
edges connecting the nodes are colored orange when leading to activation of the downstream 870 
node, blue when leading to its inhibition, and yellow if the findings underlying the relationship 871 
are inconsistent with the state of the downstream node. Pointed arrowheads indicate that the 872 
downstream node is expected to be activated if the upstream node connected to it is activated, 873 
while blunt arrowheads indicate that the downstream node is expected to be inhibited if the 874 
upstream node that connects to it is activated. 875 
 876 
Figure 4. Immunohistochemical detection of AGR2 and AREG in JSRV-infected cells. 877 
Immunohistochemical labeling of sheep lung with antibodies to JSRV SU (A, B, C) and AGR2 878 
(D, E, F).  A and D, serial adjacent sections of mock-infected sheep lung. B and E, serial sections 879 
of OPA lesions in the lung of a lamb experimentally-infected with JSRV. C and F, serial sections 880 
of lung tissue from a natural case of OPA. Brown pigment indicates positive labeling.  G, H, I, J, 881 
 o
n
 August 23, 2019 at Royal Veterinary College
http://jvi.asm.org/
D
ow
nloaded from
 
39 
immunofluorescence labeling of lung tissue of an experimentally-infected lamb.  Panel H, AGR2 882 
(green); panel I, JSRV (red).  Panel G shows staining with DAPI (blue) used to visualize nuclei 883 
and panel J shows the merged image. K, L and M, IHC labeling with an antibody to AREG. K, 884 
mock-infected lung shows labeling of some epithelial cells (arrows) and macrophages 885 
(arrowheads). L, JSRV experimentally-infected lamb and M, naturally OPA-affected sheep lung 886 
show labeling of OPA lesions.  887 
 888 
Figure 5.  Immunohistochemical detection of Hippo pathway regulators in OPA-affected 889 
lung.  890 
IHC was performed on sections of ovine lung tissue with antibodies to proteins involved in 891 
Hippo pathway signaling.  Left column, mock-infected sheep lung; middle column, 892 
experimentally-infected lamb; right column, natural OPA. Brown pigment indicates positive 893 
labeling.  A-C, total YAP1; D-F, phosphorylated (inactive) YAP1 (P-YAP1); G-I, MST1/2; J-L, 894 
LATS1/2.  Note P-YAP expression is localized in the cytoplasm of tumor cells (panels E and F), 895 
whereas total YAP1 expression is shown the nuclei and the cytoplasm of tumor cells (panels B 896 
and C). Black arrows in panels B and C indicate examples of nuclear locating YAP1. 897 
 898 
Figure 6.  RT-qPCR detection of cytokine expression in OPA. 899 
The figure shows box-whisker plots of relative expression of selected genes in OPA-affected 900 
lung tissue compared to healthy control tissue measured by RT-qPCR. A. Experimentally-901 
induced OPA relative to lung tissue from age and sex matched mock-infected lambs.  B. Natural 902 
OPA relative to healthy adult sheep lung. Data analysis was performed using the software tool 903 
REST (72), which calculates the significance of the expression ratio based on the use of two 904 
reference genes and the amplification efficiency for each gene. Significant changes in expression 905 
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are indicated by asterisks (*; standard error <0.005 at P=0.05). The dotted line within each box 906 
represents the median value, the boxed area encompasses the interquartile range and the whiskers 907 
indicate the maximum and minimum data points.  Note the difference in scales on the Y axis 908 
between the two charts.  The data are consistent with the results of RNA-Seq analysis for these 909 
genes in experimentally-infected lambs and controls, where CSF2, CCL2, CXCL8 and IL6 were 910 
upregulated, TNF was downregulated and IL1B, IL10, IL18 and IFNG were not significantly 911 
changed.  TGFB1 and IFNA were not detected by RNA-Seq although TGFB3 was upregulated. 912 
(Note that IFNA was not examined in experimental OPA.)  913 
 914 
Figure 7.  Expression of macrophage-related genes is altered in OPA. 915 
To identify macrophage-related functions in our data, a list of macrophage-related genes was 916 
compiled based on Gene Ontology (GO) terms (891 genes) and those present in macrophage 917 
coexpression clusters from the recently published sheep genome atlas (450 genes) (81) (see 918 
Supplementary Dataset S3). Combining these two lists gave a total of 1255 genes (86 were 919 
common to both sets), of which 1076 were present in our RNA-Seq data and 198 were 920 
differentially expressed in JSRV-infected lung tissue. A. Hierarchical clustering of 198 markers 921 
related to macrophage function that are differentially expressed in OPA. B. Hierarchical 922 
clustering of the 25 most significantly upregulated and downregulated macrophage-related genes 923 
in OPA. Orange coloring indicates upregulation, blue indicates downregulation. 924 
 925 
Figure 8. Immunohistochemical detection of macrophage markers in OPA-affected lung 926 
tissue. 927 
Immunohistochemistry of sheep lung labeled with antibodies to markers of macrophages. Left 928 
column, mock-infected lung; middle column, experimentally-infected lung; right hand column, 929 
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natural OPA-affected lung. Brown pigment indicates positive labeling.  A-C, labeling with an 930 
antibody to CD68. D-F, serial sections of tissues shown in panels A-C labeled with an antibody 931 
to CD163.  Note the difference in distribution of labeling with the two antibodies. G-I, labeling 932 
with an antibody to LGMN; J-L, labeling with an antibody to HIF1A.  Note that antibodies to 933 
LGMN and HIF1A label some tumor cells in addition to macrophages.  In addition, LGMN 934 
exhibits a different pattern of labeling of tumor cells in experimental and natural OPA, where 935 
experimental cases have intense cytoplasmic labeling and natural cases have prominent labeling 936 
of the apical region. 937 
 938 
Figure 9. Comparison of gene expression in OPA and human lung cancer.  939 
Genes differentially expressed in experimentally-induced OPA were compared with genes 940 
differentially expressed in human lung cancer, including clinical stages I - IV of LUAD and I - 941 
III of LUSC. (LUSC stage IV was not analyzed as there were only two samples present in the 942 
data.)  A. Correlation plot comparing differentially expressed genes in OPA with the different 943 
clinical stages of human LUAD and LUSC. The height of each bar shows the percentage of 944 
differentially expressed sheep genes that have differentially expressed orthologues in the human 945 
data set. The shading indicates the Pearson correlation coefficient between the log ratios of genes 946 
in common between the two lists.  The data confirm closer similarity of OPA to LUAD than 947 
LUSC and to stage I LUAD in particular.  B. The differentially expressed orthologous genes in 948 
both sheep and human stage I LUAD were analyzed with Ingenuity Pathway Analysis software 949 
and the figure shows the enriched Diseases and Biofunctions associated with those genes.  C. 950 
The plot shows the changes in gene expression in experimentally-induced OPA and human stage 951 
I LUAD for the 50 most significantly changed sheep genes with deregulated human orthologues. 952 
Note that 37 of the 50 genes show a similar direction of change in expression, whereas 13 show 953 
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divergent changes, highlighting similarities and differences between the sheep and human 954 
diseases. 955 
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